Mgr. Vladimír Rotrekl, Ph.D.
Head of the research group, Vladimír Rotrekl Research Group
office: bldg. A19/331
Kamenice 753/5
625 00 Brno
| phone: | +420 549 49 8002 |
|---|---|
| e‑mail: |
| social and academic networks: |
|---|
Total number of publications: 139
2023
-
Plazmatické hladiny FSTL1 a FSLT5 predikují obnovu funkce levé komory u pacientů s nově zjištěnou dilatační kardiomyopatií
Year: 2023, type: Conference abstract
2022
-
Aminophylline Induces Two Types of Arrhythmic Events in Human Pluripotent Stem Cell–Derived Cardiomyocytes
Frontiers in Pharmacology, year: 2022, volume: 12, edition: January, DOI
-
Atomic Force Spectroscopy is a promising tool to study contractile properties of cardiac cells
Micron, year: 2022, volume: 155, edition: APR, DOI
-
Detekce arytmie u dvojice klastrů kardiomyocytů s pomocí mikroskopie atomárních sil
Year: 2022, type: Appeared in Conference without Proceedings
-
DUAL CARDIOMYOCYTE CLUSTER ARRHYTHMIAS DETECTED BY ATOMIC FORCE MICROSCOPY
Year: 2022, type: Appeared in Conference without Proceedings
-
Dual cardiomyocyte cluster detection the different types of arrhythmogenic potential of caffein
Year: 2022, type: Conference abstract
-
DUCHENNE MUSCULAR DYSTROPHY: CARDIACPHENOTYPE AS A RESULT OF DNA DAMAGE-INDUCED CHANGE OF STEM CELL FATE.
Year: 2022, type: Appeared in Conference without Proceedings
-
Effects of salbutamol and ipratropium on human stem-cells derived cardiomyocytes’ function
Year: 2022, type: Conference abstract, DOI
-
hESC derived cardiomyocyte biosensor to detect the different types of arrhythmogenic properties of drugs
Analytica Chimica Acta, year: 2022, volume: 1216, edition: July 2022, DOI
-
Změny elektromechanických vlastností lidských kardiomyocytů v prostředí běžně užívaných bronchodilatancií – aminophyllin, salbutamol, ipratropium
Year: 2022, type: Appeared in Conference without Proceedings